IP Verse

Solid State Forms Of Cabazitaxel And Processes For Preparation Thereof - EP2688877

The patent EP2688877 was granted to Ivax on Mar 8, 2017. The application was originally filed on Apr 11, 2012 under application number EP12716918A. The patent is currently recorded with a legal status of "Opposition Rejected".

EP2688877

IVAX
Application Number
EP12716918A
Filing Date
Apr 11, 2012
Status
Opposition Rejected
Jul 10, 2020
Grant Date
Mar 8, 2017
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

MACKERTDec 8, 2017MACKERTADMISSIBLE

Patent Citations (12) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONUS5847170
DESCRIPTIONUS5962705
DESCRIPTIONUS7241907
DESCRIPTIONWO2009115655
INTERNATIONAL-SEARCH-REPORTUS7241907
INTERNATIONAL-SEARCH-REPORTWO2009115655
OPPOSITIONUS2013178639
OPPOSITIONUS7241907
OPPOSITIONWO2013034979
OPPOSITIONWO2013069027
OTHERWO2009115655
OTHERWO2012142117

Non-Patent Literature (NPL) Citations (9) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
OPPOSITION- "1.2.2 Pseudopolymorphism, solvates, and hydrates", Joel Bernstein, Polymorphism in Molecular Crystals, Clarendon Press, (20020101), pages 4 - 5, XP055444454-
OPPOSITION- "1.4 Crystal hydrates", Florence et al., Physicochemical Principles of Pharmacy, Pharmaceutical Press, (20060000), page 19, XP055444457-
OPPOSITION- "Isolation and purification", Sharp et al., Practical Organic Chemistry, pages 64 - 90, XP055444444-
OPPOSITION- Kumar et al., "Host-guest complexes of docetaxel, an anti-cancer drug", Journal of Inclusion Phenomena and Macrocylic Chemistry, vol. 66, no. 3-4, (20090626), pages 269 - 269, XP019790683-
OPPOSITION- Karpinski, "Polymorphism of Active Pharmaceutical Ingredients", Chem. Eng. Technol,, vol. 29, no. 2, (20060101), pages 233 - 237, XP055445017
OPPOSITION- VIPPAGUNTA S R, et al., "CRYSTALLINE SOLIDS", Advanced Drug Delivery Reviews, (20010101), pages 3 - 26, XP001181963
OPPOSITION- Liggins et al., "Solid-State Characterization of Paclitaxel", Journal of Pharmaceutical Sciences, vol. 86, no. 12, (19971201), pages 1458 - 1463, XP009027537
OPPOSITION- Byrn et al, "Pharmaceutical Solids: A strategic Approach to Regulatory Considerations", Pharmaceutical Research, (19950101), pages 945 - 954, XP055399407
OPPOSITION- Lee et al., "Crystal polymorphism in chemical process development", Annual Review of Chemical and Biomolecular Engineering, vol. 2, pages 259 - 280, XP009177161

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents